SG3 Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,500
Closed -$222K 521
2022
Q1
$222K Sell
8,500
-1,500
-15% -$39.9K 0.01% 744
2021
Q4
$284K Buy
+10,000
New +$311K 0.01% 750
2021
Q1
Sell
-4,000
Closed -$123K 1256
2020
Q4
$123K Buy
+4,000
New +$122K ﹤0.01% 909
2019
Q2
Sell
-152,500
Closed -$4.89M 432
2019
Q1
$4.89M Buy
+152,500
New +$4.69M 0.48% 50

Other funds holding ELAN

SG3 Management's ELAN Position: Q2 2022 in Review

SG3 Management sold out of Elanco Animal Health (ELAN) in Q2 2022, closing a stake of 8,500 shares — an estimated $222K sold.

SG3 Management first reported a position in ELAN in Q1 2019 and held it in 4 quarters. The position peaked at $4.89M in Q1 2019. 439 funds tracked by Wall St. Rank hold ELAN as of Q2 2022.

  • SG3 Management reported no remaining Elanco Animal Health position as of Q2 2022 after selling out during the quarter.
  • SG3 Management sold 8,500 Elanco Animal Health shares in Q2 2022, an estimated $222K.
  • SG3 Management first reported a position in Elanco Animal Health in Q1 2019 and held it in 4 quarters.
  • SG3 Management's Elanco Animal Health position peaked at $4.89M in Q1 2019.
  • 439 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.